
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Results from the first Patient Power Cancer Clinical Trials Survey show that the majority of patients surveyed were interested in taking part in clinical trials. The survey also found that patients who participated in clinical studies-some of them in more than one-found them to be of clinical benefit.
To learn more of the report's findings, click






